Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lung Cancer Screening Program in Mexico
Sponsor: Instituto Nacional de Cancerologia de Mexico
Summary
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.
Official title: Lung Cancer Early Detection With Low-dose Computed Tomography in High-risk Individuals: Experience in Mexico
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2022-03-24
Completion Date
2027-03-24
Last Updated
2025-12-24
Healthy Volunteers
Yes
Conditions
Interventions
Screening
Annual LDCT, lung function test (spirometry), anxiety/depression assessments, and serum biomarkers tests over 3 years. Follow-up will continue for 5 and 10 years or until event completion (cancer diagnosis, end of follow-up, or death).
Locations (1)
Instituto Nacional de Cancerologia (INCan) Mexico
Mexico City, Tlalpan, Mexico